Company Analysis
Sign in

Precipio, Inc. (PRPO)

Nasdaq: PRPO · Laboratory Analytical Instruments · New Haven, CT · filing with the SEC since 2000
Full chart Alerts Compare
Grade5.0
◀ Past 4.1● Present 5.8▶ Future 4.9
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

69 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Precipio, Inc.’s names, not what it holds today.

Patents granted
69
69 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
14
1 of them in 2025
Names they are printed under
3
a former name, its own name
By yearGrantedApplications published
'01'02'03'04'05'06'07'09'10'12'13'14'15'19'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name3 counted
Transgenomic, Inc. a former name
US, as the owner printed on each patent
69 granted
10 published
Precipio, Inc. its own name
named as the applicant on its applications, in US
0 granted
2 published
Transgenomic, Inc. a former name
named as the applicant on its applications, in US. 1 more under the same name are not counted (printed in NE)
0 granted
2 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 15, 20159,133,490Step-up method for COLD-PCR enrichmentBiotechnologyTransgenomic, Inc.
Feb 25, 20148,658,358Mutations associated with long QT syndromeBiotechnologyTransgenomic, Inc.
Jul 6, 20107,749,708Method for identifying the sequence of one or more variant nucleotides in a nucleic acid moleculeBiotechnologyTransgenomic, Inc.
Aug 25, 20097,579,155Method for identifying the sequence of one or more variant nucleotides in a nucleic acid moleculeBiotechnologyTransgenomic, Inc.
Jul 14, 20097,560,261Nucleic acid sequences encoding CEL II endonucleaseBiotechnologyTransgenomic, Inc.
May 29, 20077,225,079System and method for automated matched ion polynucleotide chromatographyMeasurementTransgenomic, Inc.
Jan 30, 20077,169,298Method and apparatus for separating polynucleotides using monolithic capillary columnsChemical engineeringTransgenomic, Inc.
Nov 21, 20067,138,518Liquid chromatographic separation of polynucleotidesBiotechnologyTransgenomic, Inc.
Nov 14, 20067,135,289Methods and compositions for mutation analysis of polynucleotides by liquid chromatographyChemical engineeringTransgenomic, Inc.
Oct 31, 20067,129,075Isolated CEL II endonucleaseBiotechnologyTransgenomic, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 18, 20252025/0290146METHODS AND COMPOSITIONS FOR SCREENING FOR MYELOPROLIFERATIVE DISORDERSBiotechnologyPrecipio, Inc.
Dec 19, 20192019/0382727CULTURE MEDIA FOR SIMULTANEOUS TESTING OF MULTIPLE HEMATOPOIETIC DISEASE TYPESBiotechnologyPrecipio, Inc.
Jan 15, 20152015/0018229POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONSBiotechnologyTransgenomic, Inc.
Nov 21, 20132013/0309724STEP-UP METHOD FOR COLD-PCR ENRICHMENTBiotechnologyTransgenomic, Inc. · patent 9,133,490 granted from it
Sep 6, 20122012/0225421KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATIONBiotechnologyTransgenomic, Inc.
Sep 30, 20042004/0191769Methods, compositions, and kits for mutation detection in mitochondrial DNABiotechnologyTransgenomic, Inc.
Feb 26, 20042004/0035793Methods, systems, and kits for analysis of polynucleotidesMeasurementTransgenomic, Inc.
Dec 4, 20032003/0225261Methods and compositions for mutation analysis of polynucleotides by liquid chromatographyMeasurementTransgenomic, Inc. · patent 7,135,289 granted from it
Nov 13, 20032003/0211457Methods and kits for testing mutagenicityBiotechnologyTransgenomic, Inc.
Sep 4, 20032003/0165941System and method for automated matched ion polynucleotide chromatographyBiotechnologyTransgenomic, Inc. · patent 7,225,079 granted from it
What it applied for, 2024 to 2025: Biotechnology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PRPO · research, not advice